Cytotechnologist onsite laboratory testing and research support service
Ended Awarded Last action
- Contract number
- 75N91019F90034
- Awardee
-
Astrix Technology LLC UEI NRVNN8E6NCK4
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $21,168
Award facts
- Contract value 100% obligated
- $21,168.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541611 Administrative Management and General Management Consulting Services
- PSC
- R699 Support- Administrative: Other
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Bethesda, MD 20892, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$3,808 | |
| Original award | $24,976 |
About this award
The National Cancer Institute (NCI) awarded a $21,168 firm fixed price Blanket Purchase Agreement (BPA) call to Astrix Technology LLC for cytotechnologist onsite laboratory testing and research support services. The contract was awarded on April 1, 2019, with an ultimate completion date of February 29, 2024, and was performed in Bethesda, Maryland. This award carried no set-aside designation, indicating unrestricted competition. The contract was issued to de-obligate funds from expiring FY2019 lines in accordance with NIH Office of Acquisition and Logistics Management communication.
Astrix Technology LLC, a Red Bank, New Jersey-based limited liability company, specializes in providing scientific, research, technical, and administrative support services to federal biomedical research agencies. The company holds a $20 million single-award BPA with the NIH's Office of Logistics and Acquisition Operations through May 31, 2025, which enables flexible staffing solutions across NIH institutes. Astrix Technology has demonstrated consistent capability in supporting diverse research initiatives at multiple NIH institutes, including the National Cancer Institute, through roles spanning scientific researchers, clinical research nurses, laboratory technicians, and other specialized personnel. This contract represents one task order under Astrix Technology's broader NIH BPA portfolio.
Quick answers
Who was awarded contract 75N91019F90034?
75N91019F90034 was awarded to Astrix Technology LLC by National Cancer Institute (National Institutes of Health) on April 1, 2019.
How much is contract 75N91019F90034 worth?
The government has obligated $21,168 on 75N91019F90034.
Is contract 75N91019F90034 an order under another contract?
Yes. 75N91019F90034 is a BPA call under HHSN263201200066B, a blanket purchase agreement.
Was contract 75N91019F90034 competed?
The extent of competition for 75N91019F90034 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award